Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of
semiconductor test and reliability qualification equipment, today
announced financial results for its fiscal 2020 fourth quarter and
full year ended May 31, 2020.
Fiscal Fourth Quarter Financial Results:
- Net sales were $3.8 million, compared to $7.2 million in the
fourth quarter of fiscal 2019.
- GAAP net loss was $2.9 million, or $0.13 per diluted share, and
includes approximately $1.9 million in charges, or $0.08 per share,
consisting of a $1.6 million adjustment for excess and obsolete
inventory and a $220,000 adjustment related to workforce reductions
in the Company’s German and Japan subsidiaries as part of the
Company’s cost reduction initiatives announced during its third
quarter conference call. This compares to GAAP net income of
$110,000, or $0.00 per diluted share, that included $118,000 in
restructuring charges, or $0.01 per share, in the fourth quarter of
2019.
- Non-GAAP net loss was $720,000, or $0.03 per diluted share,
which excludes the impact of stock-based compensation,
restructuring charges and adjustment for excess and obsolete
inventory, compared to non-GAAP net income of $428,000, or $0.02
per diluted share, in the fourth quarter of fiscal 2019.
Fiscal Year Financial Results:
- Net sales were $22.3 million, compared to $21.1 million in
fiscal 2019.
- GAAP net loss was $2.8 million, or $0.12 per diluted share, and
includes approximately $1.9 million in inventory reserve and
restructuring charges, or $0.08 per share, compared to a GAAP net
loss of $5.2 million, or $0.23 per diluted share, and includes
approximately $1.5 million in inventory reserve and restructuring
charges, or $0.07 per share, in fiscal 2019.
- Non-GAAP net loss was $27,000, or $0.00 per diluted share,
which excludes the impact of stock-based compensation expense,
restructuring charges and adjustment for excess and obsolete
inventory, compared to a non-GAAP net loss of $2.8 million, or
$0.13 per diluted share, in fiscal 2019.
- Backlog as of May 31, 2020 was $2.5 million, compared to $7.5
million as of May 31, 2019.
An explanation of the use of non-GAAP financial information and
a reconciliation of the non-GAAP financial measures to the most
directly comparable GAAP financial measures can be found in the
accompanying tables.
Fourth Quarter and Fiscal Year 2020
Business Highlights:
- Closed New Order with
Major New Customer in Silicon Photonics – During
the quarter, closed initial order with a major global leader of
communication transceivers for data centers, telecom, and 5G
infrastructure for a FOX™ full wafer level test and burn-in system
for production stabilization and test of their Silicon Photonics
devices.
- Closed Initial Order with World’s Largest OSAT
– During the quarter, closed initial order with the
world’s largest Outsourced Semiconductor Assembly and Test (OSAT)
supplier to use the FOX-P™ family of products including Aehr
WaferPaks™ and DiePaks® for production test, burn-in, and
reliability screening of devices at full wafer, singulated die, and
module level.
- Added Key New Market with Silicon Carbide Devices in
FY20 – Added significant new customer and market
opportunity with initial orders from leading semiconductor device
supplier for a FOX multi-wafer system and proprietary WaferPaks for
high volume production burn-in and infant mortality screening of
Silicon Carbide devices at wafer level for Electric Vehicle power
modules.
- Industry Adopted Production Wafer Level Burn-in (WLBI)
in FY20 – Made significant progress with its new FOX
products for Wafer and Singulated Die Test and Burn-in during the
fiscal year with three key Tier 1 customers added and five
customers transitioning to production with 100% stabilization
and/or infant mortality reliability screening with its FOX
products.
- FY20 Second Half Saw Pushouts in Silicon Photonics
Ramps – Company experienced push outs of customer
forecasted orders in its second fiscal half of FY20 for its FOX-P
Systems and consumables in data center and some 5G end use
applications for Silicon Photonics transceivers. These customers
have indicated the push outs are temporary and that they will
require the additional system capacity and consumables in the
current fiscal 2021 year.
- Shipments of Consumables were Significant
Percentage of Revenue – Shipments of WaferPak
Contactors and DiePak Carrier consumables for Aehr’s FOX wafer and
singulated die/module test and burn in systems accounted for 48% of
total revenue in fiscal 2020.
- Aehr Engaged with Over a Dozen New Potential Customers
– Company is engaged with over one dozen additional Tier 1
and Tier 2 customers that are considering using the company’s
products for high market growth applications including Silicon
Photonics and Silicon Carbide production burn-in. Several of these
companies are expected to place their initial orders this fiscal
2021 year with ramps into production later in this fiscal year
and/or the following fiscal year.
- Completed Planned Restructuring and Shift to Higher
Margin Products in FY20 – The company completed its
previously announced restructuring and also moved to much higher
margin FOX systems and consumables during the fiscal year. As a
result, the company is profitable at much lower revenue numbers and
has greater leverage to achieve higher profitability moving
forward.
Gayn Erickson, President and CEO of Aehr Test
Systems, commented:
“We made substantial progress with our new FOX products for
wafer and singulated die test and burn-in during the year that
strengthened our customer base, expanded our markets, and enhanced
our operations and sales capabilities to capitalize on the
significant market opportunities we see ahead.
“We added three key Tier 1 customers this past fiscal year. We
now have six significantly large Tier 1 customers with applications
and market sizes that are each capable of driving sales of $6
million to $10 million or more per year of our FOX wafer level and
singulated die test systems and consumables. We also have another
seven Tier 2 customers that are each capable of FOX product sales
typically within $1 million to $3 million per year. In addition,
five of our customers moved to production during the fiscal year
using our FOX products for 100% stabilization or infant mortality
burn-in of devices.
“This past fiscal year we successfully installed our first
production capacity for silicon carbide devices, adding it to the
list of markets such as silicon photonics, 2D & 3D sensors,
automotive, and lasers used in photonics devices that have shown
the value and feasibility of using our FOX solutions to address
these market needs. We see an increasing awareness and adoption
rate that we believe could drive the majority of the market for
silicon carbide as well as silicon photonics to move to wafer level
or singulated die burn-in within the next few years.
“This new silicon carbide application with a Fortune 500 market
leader in silicon carbide and power modules adds a significant new
Tier 1 customer of our FOX-XP™ system and WaferPaks for whole wafer
burn-in and infant mortality screening of silicon carbide (SIC)
devices. Since our initial installation in January, we have
received multiple follow on orders for additional WaferPaks
including multiple new designs and now have a significant number of
different devices that have been put into production. This customer
is forecasting additional capacity needs for our FOX-XP Wafer Level
Test & Burn-in systems during this fiscal year and for years
into the future.
“We saw our silicon photonics customers move to production for
the first time in fiscal 2020. During the fiscal year, we saw our
lead customer for silicon photonics move to full volume production
for the first time. We expect them to purchase additional systems
this fiscal year and into the future as they continue to maintain
or grow their market share and add additional silicon photonics
devices to the mix. We also moved three additional silicon
photonics customers to production with our FOX systems in fiscal
2020. All three of these customers are expected to ramp production
during this fiscal 2021, adding capacity in both systems and
consumables. Near fiscal year end, we announced another new silicon
photonics customer that will deploy our FOX-NP™ system for initial
production burn-in and stabilization of their high performance
silicon photonic devices, and has forecasted to then transition to
our FOX-XP wafer-level test and burn-in systems during this fiscal
year to meet their volume production forecast.
“We see the total available opportunity for silicon carbide and
silicon photonics wafer level and singulated die test markets to be
approximately $250 million of needed capacity including
consumables. We are currently engaged with over a dozen potential
Tier 1 and Tier 2 customers for both silicon photonics and silicon
carbide applications, and we expect several of these potential
customers to place initial orders this fiscal year, with ramps into
production later in the current fiscal year or in fiscal 2022. We
are also seeing renewed activity and interest for our FOX systems
and consumables for several new applications in the 2D and 3D
sensor markets particularly for mobile devices and believe this
could add to our currently forecasted revenue for this fiscal year
and next.
“Although COVID-19 has created challenges such as international
travel, some small impacts on our supply chain, and caution and/or
delays with some customer production ramps, we believe there will
be no long-term impact to Aehr, the demand for our products, or for
the attractiveness of the key markets that we serve. We absolutely
believe that we will come out of this worldwide pandemic stronger
than we went in with more production customers, more applications,
and higher value products. Our key customers’ products are being
used to build out new data centers, improve data rates and increase
storage in data centers, build out of the 5G infrastructure, enable
the newest sensors and technology in smartphones and tablets,
enable the wide spread adoption of electric and hybrid electrics
vehicles and charging stations, and address the unstoppable demand
for memory and data storage in computing, data centers, mobile
devices and hundreds of applications that are keeping the world
connected.
“As we move into fiscal 2021, we remain optimistic about growth
in systems and consumables within our installed base of customers
as well as expanding the number of customers with our family of
FOX-P solutions. We expect significant growth in both our top and
bottom lines moving forward, with much lower fixed operating
expenses and significantly higher margin products and
services.”
Fiscal 2021 Financial Guidance:For the fiscal
year ending May 31, 2021, the Company expects full year total
revenue to be between $25 million and $28 million, which would
represent growth between 12% and 26% year over year, and to be
profitable for the fiscal year.
Management Conference Call and
WebcastAehr Test Systems will host a conference call and
webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its
fiscal 2020 fourth quarter and full year operating results. To
access the call dial 800-367-2403 (+1 334-777-6978 outside the
United States) and give the participant pass code 7836578. In
addition, a live and archived webcast of the conference call will
be available over the Internet at www.aehr.com in the Investor
Relations section. A replay of the conference call will also be
available via telephone beginning approximately two hours after
conclusion of the call through 8:00 p.m. ET on July 23, 2020. To
access the replay dial-in information, please click here.
About Aehr Test SystemsHeadquartered in
Fremont, California, Aehr Test Systems is a worldwide provider of
test systems for burning-in and testing logic, optical and memory
integrated circuits and has installed over 2,500 systems worldwide.
Increased quality and reliability needs of the Automotive and
Mobility integrated circuit markets are driving additional test
requirements, incremental capacity needs, and new opportunities for
Aehr Test products in package, wafer level, and singulated
die/module level test. Aehr Test has developed and introduced
several innovative products, including the ABTS™ and FOX-P™
families of test and burn-in systems and FOX WaferPak™ Aligner,
FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak
Loader. The ABTS system is used in production and qualification
testing of packaged parts for both lower power and higher power
logic devices as well as all common types of memory devices. The
FOX-XP and FOX-NP systems are full wafer contact and singulated
die/module test and burn-in systems used for burn-in and functional
test of complex devices, such as leading-edge memories, digital
signal processors, microprocessors, microcontrollers,
systems-on-a-chip, and integrated optical devices. The FOX-CP
system is a new low-cost single-wafer compact test and reliability
verification solution for logic, memory and photonic devices and
the newest addition to the FOX-P product family. The WaferPak
contactor contains a unique full wafer probe card capable of
testing wafers up to 300mm that enables IC manufacturers to perform
test and burn-in of full wafers on Aehr Test FOX systems. The
DiePak Carrier is a reusable, temporary package that enables IC
manufacturers to perform cost-effective final test and burn-in of
both bare die and modules. For more information, please visit Aehr
Test Systems’ website at www.aehr.com.
Safe Harbor Statement This press release
contains certain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements
generally relate to future events or Aehr’s future financial or
operating performance. In some cases, you can identify
forward-looking statements because they contain words such as
"may," "will," "should," "expects," "plans," "anticipates,” “going
to,” "could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential," or "continue," or
the negative of these words or other similar terms or expressions
that concern Aehr’s expectations, strategy, priorities, plans, or
intentions. Forward-looking statements in this press release
include, but are not limited to, statements regarding the temporary
nature of customer pushouts and customer needs for additional
system capacity and consumables in fiscal year 2021; the impact of
Aehr’s restructuring on its ability to achieve higher future
profitability; the ability of current awareness and adoption rates
to drive the markets for silicon carbide and silicon photonics to
move to wafer level or singulated die burn-in; customer capacity
needs forecasts related to Aehr’s FOX-XP Wafer Level Test &
Burn-in systems; our expectations related to the timing and volume
of our lead customer’s future purchases; the total available
opportunity for silicon carbide and silicon photonics wafer level
and singulated die test markets; expectations regarding the timing
and occurrence of initial and subsequent orders of potential
customers and the related impact on Aehr’s forecasted revenues;
increases in Aehr’s customers, applications and product value after
the COVID-19 pandemic; growth in systems and consumables within
Aehr’s installed base of customers and expansion of the number of
customer’s in Aehr’s FOX-P solutions; Aehr’s top and bottom line
growth, lower fixed operating expenses and higher margin products
and services in 2021; and Aehr’s revenue in fiscal 2021. The
forward-looking statements contained in this press release are also
subject to other risks and uncertainties, including those more
fully described in Aehr’s recent 10-K, 10-Q and other reports from
time to time filed with the Securities and Exchange Commission.
Aehr disclaims any obligation to update information contained in
any forward-looking statement to reflect events or circumstances
occurring after the date of this press release.
Contacts: |
|
|
|
Aehr Test Systems |
MKR Investor Relations Inc. |
Ken Spink |
Todd Kehrli or Jim Byers |
Chief Financial Officer |
Analyst/Investor Contact |
(510) 623-9400 x309 |
(323) 468-2300 |
aehr@mkr-group.com |
|
– Financial Tables to Follow
–
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
Condensed
Consolidated Statements of Operations |
(in thousands,
except per share data) |
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
|
|
|
May 31, |
|
Feb 29, |
|
May 31, |
|
May 31, |
|
May 31, |
|
|
|
|
2020 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
$ |
3,773 |
|
|
$ |
6,111 |
|
|
$ |
7,242 |
|
|
$ |
22,291 |
|
|
$ |
21,056 |
|
|
Cost of sales |
|
3,866 |
|
|
|
3,120 |
|
|
|
3,863 |
|
|
|
13,920 |
|
|
|
13,454 |
|
|
Gross (loss) profit |
|
(93 |
) |
|
|
2,991 |
|
|
|
3,379 |
|
|
|
8,371 |
|
|
|
7,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
1,674 |
|
|
|
1,891 |
|
|
|
2,018 |
|
|
|
7,530 |
|
|
|
7,724 |
|
|
Research and development |
|
854 |
|
|
|
845 |
|
|
|
1,120 |
|
|
|
3,386 |
|
|
|
4,153 |
|
|
Restructuring |
|
220 |
|
|
|
- |
|
|
|
118 |
|
|
|
220 |
|
|
|
725 |
|
|
Total operating expenses |
|
2,748 |
|
|
|
2,736 |
|
|
|
3,256 |
|
|
|
11,136 |
|
|
|
12,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from operations |
|
(2,841 |
) |
|
|
255 |
|
|
|
123 |
|
|
|
(2,765 |
) |
|
|
(5,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest (expense) income, net |
|
(17 |
) |
|
|
13 |
|
|
|
(24 |
) |
|
|
10 |
|
|
|
(252 |
) |
|
Other (expense) income, net |
|
(17 |
) |
|
|
(9 |
) |
|
|
17 |
|
|
|
(11 |
) |
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income tax expense |
|
(2,875 |
) |
|
|
259 |
|
|
|
116 |
|
|
|
(2,766 |
) |
|
|
(5,208 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
(10 |
) |
|
|
(14 |
) |
|
|
(6 |
) |
|
|
(36 |
) |
|
|
(27 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
(2,885 |
) |
|
|
245 |
|
|
|
110 |
|
|
|
(2,802 |
) |
|
|
(5,235 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to the noncontrolling interest |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss)
income attributable to Aehr Test Systems common shareholders |
$ |
(2,885 |
) |
|
$ |
245 |
|
|
$ |
110 |
|
|
$ |
(2,802 |
) |
|
$ |
(5,235 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per share |
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.13 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
(0.12 |
) |
|
$ |
(0.23 |
) |
|
Diluted |
$ |
(0.13 |
) |
|
$ |
0.01 |
|
|
$ |
0.00 |
|
|
$ |
(0.12 |
) |
|
$ |
(0.23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
|
Basic |
|
23,060 |
|
|
|
22,937 |
|
|
|
22,605 |
|
|
|
22,882 |
|
|
|
22,387 |
|
|
Diluted |
|
23,060 |
|
|
|
23,130 |
|
|
|
22,717 |
|
|
|
22,882 |
|
|
|
22,387 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
|
|
Reconciliation of GAAP and Non-GAAP Results |
|
|
(in thousands,
except per share data) |
|
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Year Ended |
|
|
|
|
|
May 31, |
|
Feb 29, |
|
May 31, |
|
May 31, |
|
May 31, |
|
|
|
|
|
|
2020 |
|
|
2020 |
|
2019 |
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net (loss) income |
|
$ |
(2,885 |
) |
|
$ |
245 |
|
$ |
110 |
|
$ |
(2,802 |
) |
|
$ |
(5,235 |
) |
|
|
Stock-based compensation expense |
|
|
300 |
|
|
|
207 |
|
|
200 |
|
|
910 |
|
|
|
905 |
|
|
|
Restructuring |
|
|
220 |
|
|
|
- |
|
|
118 |
|
|
220 |
|
|
|
725 |
|
|
|
Excess and obsolescence provision |
|
|
1,645 |
|
|
|
- |
|
|
- |
|
|
1,645 |
|
|
|
795 |
|
|
|
Non-GAAP net (loss) income |
|
$ |
(720 |
) |
|
$ |
452 |
|
$ |
428 |
|
$ |
(27 |
) |
|
$ |
(2,810 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net (loss) income per diluted share |
|
$ |
(0.13 |
) |
|
$ |
0.01 |
|
$ |
0.00 |
|
$ |
(0.12 |
) |
|
$ |
(0.23 |
) |
|
|
Non-GAAP net (loss) income per diluted share |
|
$ |
(0.03 |
) |
|
$ |
0.02 |
|
$ |
0.02 |
|
$ |
(0.00 |
) |
|
$ |
(0.13 |
) |
|
|
Shares used in GAAP diluted shares calculation |
|
|
23,060 |
|
|
|
23,130 |
|
|
22,717 |
|
|
22,882 |
|
|
|
22,387 |
|
|
|
Shares used
in non-GAAP diluted shares calculation |
|
|
|
23,060 |
|
|
|
23,130 |
|
|
22,717 |
|
|
22,882 |
|
|
|
22,387 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net (loss)
income is a non-GAAP measure and should not be considered a
replacement for GAAP results. Non-GAAP net (loss) income is a
financial measure the Company uses to evaluate the underlying
results and operating performance of the business. The limitation
of this measure is that it excludes items that impact the Company's
current period net income. This limitation is best addressed by
using this measure in combination with net (loss) income (the most
directly comparable GAAP financial measure). These measures are not
in accordance with GAAP and may differ from non-GAAP methods of
accounting and reporting used by other companies. We believe these
measures enhance investors’ ability to review the company’s
business from the same perspective as the company’s management and
facilitate comparisons of this period’s results with prior
periods. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST
SYSTEMS AND SUBSIDIARIES |
|
Condensed
Consolidated Balance Sheets |
|
(in thousands,
except per share data) |
|
(unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
May 31, |
|
February 29, |
|
May 31, |
|
|
|
|
|
|
2020 |
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
5,433 |
|
|
$ |
5,058 |
|
|
$ |
5,428 |
|
|
|
Accounts receivable, net |
|
3,717 |
|
|
|
3,511 |
|
|
|
4,859 |
|
|
|
Inventories |
|
|
7,989 |
|
|
|
9,330 |
|
|
|
9,061 |
|
|
|
Prepaid expenses and other |
|
512 |
|
|
|
586 |
|
|
|
686 |
|
|
|
Total current assets |
|
17,651 |
|
|
|
18,485 |
|
|
|
20,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
663 |
|
|
|
783 |
|
|
|
1,045 |
|
|
|
Operating lease right-of-use assets |
|
2,107 |
|
|
|
2,260 |
|
|
|
- |
|
|
|
Other assets |
|
|
153 |
|
|
|
160 |
|
|
|
228 |
|
|
|
Total assets |
$ |
20,574 |
|
|
$ |
21,688 |
|
|
$ |
21,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Current portion of long-term debt |
$ |
653 |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
Accounts payable |
|
945 |
|
|
|
925 |
|
|
|
1,933 |
|
|
|
Accrued expenses |
|
1,439 |
|
|
|
1,373 |
|
|
|
2,034 |
|
|
|
Operating lease liabilities, short-term |
|
658 |
|
|
|
644 |
|
|
|
- |
|
|
|
Customer deposits and deferred revenue, short-term |
|
|
|
170 |
|
|
|
385 |
|
|
|
1,545 |
|
|
|
Total current liabilities |
|
3,865 |
|
|
|
3,327 |
|
|
|
5,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion |
|
1,026 |
|
|
|
- |
|
|
|
- |
|
|
|
Deferred rent |
|
|
- |
|
|
|
- |
|
|
|
153 |
|
|
|
Operating lease liabilities, long-term |
|
1,605 |
|
|
|
1,772 |
|
|
|
- |
|
|
|
Deferred revenue, long-term |
|
22 |
|
|
|
34 |
|
|
|
189 |
|
|
|
Total liabilities |
|
6,518 |
|
|
|
5,133 |
|
|
|
5,854 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Aehr Test Systems shareholders' equity |
|
14,077 |
|
|
|
16,575 |
|
|
|
15,472 |
|
|
|
Noncontrolling interest |
|
(21 |
) |
|
|
(20 |
) |
|
|
(19 |
) |
|
|
Total shareholders' equity |
|
14,056 |
|
|
|
16,555 |
|
|
|
15,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity |
$ |
20,574 |
|
|
$ |
21,688 |
|
|
$ |
21,307 |
|
|
|
|
|
|
|
|
|
|
|
|
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Apr 2023 to Apr 2024